References
- Jamal A, Tiwari RC, Murray T, Ghafoor A. Cancer statistics 2007. CA Cancer J Clin 2007;57:43–66.
- Hudson T, Denis LJ. Europa Uomo: the European Prostate Cancer Coalition. Recent Results Cancer Res 2007;175:267–71.
- Konig JE, Senge T, Alhoff EP, Konig W. Analysis of the inflammatory network in benign prostate hyperplasia and prostatic cancer. Prostate 2004;58:121–31.
- Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Prostatic hyperplasia and the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol 2001;158:1767–72.
- De Marzo AM, March VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985–90.
- Sciarra A, Di Silverio F, Salciccia S, Gomez AAG, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007;52:964–72.
- De Nunzio C, Kramer G, Marberger M, Nelson W, Schröder F, Sciarra A, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011;60:106–17.
- Fleshner NE, Klotz LH. Diet, androgens, oxidative stress and prostate cancer susceptibility. Am J Pathol 1998;17:325–31.
- Billis A, Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 2003;127:840–9.
- Putz MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high grade prostatic intraepithelial neoplasia. Urology 2000;56:828–34.
- Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–9.
- Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276–83.
- Irani J, Levillian P, Gouion JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostatic specific antigen value. J Urol 1997;157:1301–3.
- Rosen RC, Riley A, Wagner G, Osterloh JH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–8.
- Elkahawji JE, Zhong W, Bushman W. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 2007;67:14–21.
- Martinon F, Petrilli V, Myor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237–41.
- Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366–81.
- Naber K, Weidner W. Chronic prostatitis: an infectious diseases? J Antimicrob Chemother 2000;46:157–61.
- Dennis L, Lynch CF, Tornes JC. Epidemiologic association between prostatitis and prostate cancer. Urology 2002;60:78–83.
- Karakiewicz PI, Banayoun S, Begin LR. Chronic inflammation is negatively associated with prostate cancer and high grade intraepithelial neoplasia on needle biopsy. Int J Clin Pract 2007;71:425–30.
- Goldstraw MA, Fitzpatrick JM, Kirby RS. What is the role of inflammation in the pathogenesis of prostate cancer? BJU Int 2007;15:1–2.
- Di Silverio F, Gentile V, de Matteis A. Distribution of inflammation, premalignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 2003;43:164–75.
- Nickel JG. Prostatic inflammation in BPH: the third component? Can J Urol 1994;1:1–4.
- Crawford ED, Wilsson SS, Roehrborn CG. MTPOS Study Group. Baseline factors as predictors of clinical progression of benign prostate hyperplasia in men treated with placebo. J Urol 2006;175:1422–7.